Immunotherapy Clinical Trial at Overlook Medical Center Reveals Brain Tumor Shrinkage, Continues with Phase 3 Study – TAPinto.net
TAPinto.net |
Immunotherapy Clinical Trial at Overlook Medical Center Reveals Brain Tumor Shrinkage, Continues with Phase 3 Study
TAPinto.net “In contrast, Phase 1 results of the immunotherapy trial showed median longevity of 14.4 months for patients with recurrent disease and patients with complete tumor shrinkage are still alive almost three years after starting the Toca regimen,” adds Dr … |
